Becker's Healthcare March 16, 2023
Noah Schwartz

The FDA has updated its guidance on using EHRs and electronic signatures in clinical trials to account for technological advances since the agency last updated its guidance in 2017, RegulatoryFocus reported March 15.

The updates provide recommendations for applying data integrity and data security tools to clinical trials.

The agency reiterated that sponsors and entities are responsible for ensuring that the records they submit through vendors comply with FDA regulations.

“In addition,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, EMR / EHR, FDA, Govt Agencies, Health IT, Technology, Trends
AI Models Continue to Gain Clinicians’ Attention
Colon-cancer blood test earns safety endorsement from FDA panel
FDA considers 2nd blood test for colon cancer — but advisers note concerns
With Duchenne decision ahead, FDA’s Marks pushes for speedy gene therapy approvals
FDA blesses Pfizer with priority review voucher for Paxlovid nod

Share This Article